Cell Culture Reagents Industry Size

The report "Cell Culture Reagents Market by Type (Growth Factors, Supplements, Cell Dissociation Reagents, Buffers & Chemicals, Others), Application (mAbs, Vaccines, CGT), End User (Pharma Biotech, Diagnostic Labs, Academia, Others), Region – Global Forecast to 2030 " is projected to grow from USD 5.06 billion in 2025 and to reach USD 8.95 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 12.1% during the forecast period.

Browse 600 market data Tables and 45 Figures spread through 650 Pages and in-depth TOC on "Cell Culture Reagents Market by Type (Growth Factors, Supplements, Cell Dissociation Reagents, Buffers & Chemicals, Others), Application (mAbs, Vaccines, CGT), End User (Pharma Biotech, Diagnostic Labs, Academia, Others), Region – Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/cell-culture-reagents-market-52737241.html

Global demand for reagents used in cell culture is increasing as cell-based research and biomanufacturing are becoming central to modern drug development. The use of cell culture in early-stage screening, biologics development, and quality testing is driving higher demand for reliable, reproducible media, feeds, supplements, buffers, and cell dissociation reagents. The growth of cell and gene therapies has contributed to the need for controlled, scalable, and well-documented reagent systems, particularly serum-free and chemically defined formulations.

The growth factors segment is expected to register the fastest growth during the forecast period of 2025 to 2030.

By type, the cell culture reagents market is divided into growth factors, supplements, buffers & chemicals, cell dissociation reagents, balanced salt solutions, attachment & matrix factors, antibiotics/antimycotics, cryoprotective reagents, contamination detection kits, and other cell culture reagents. This is driven by the rapid scale-up of cell and gene therapy programs, in which growth factors and cytokines are repeatedly used for cell activation, expansion, and differentiation. Adoption is also rising in stem cell, organoid, and iPSC workflows, where defined growth-factor cocktails are essential for consistent outcomes.

The pharmaceutical & biotechnology companies segment is expected to be the largest segment in the cell culture reagents market.

By end user, the market for cell culture reagents has been segmented into pharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, research & academic institutes, and other end users. The pharmaceutical and biotechnology companies segment accounted for the largest share of the market in 2024 and is also the fastest-growing end-user segment. Growth is supported by an expanding biologics pipeline and a higher number of programs moving from development into clinical and commercial manufacturing, which drive repeat consumption of media, feeds, supplements, and buffers across the seed train and production.

The Asia Pacific is expected to be the fastest-growing region in the global cell culture reagents market during the forecast period.

The global cell culture reagents market is segmented by region into North America, Europe, the Asia-Pacific, Latin America, the Middle East, and Africa. The Asia-Pacific region is experiencing significant growth. The main reasons for this are the large investments in Singapore, such as AbbVie's biologics capacity expansion and Novartis' antibody manufacturing expansion with automation, which are driving steady and increasing demand for media, feeds, supplements, and buffers at the production scale. Therefore, as biomanufacturing capacity is distributed across different hubs, the region is likely to experience significant growth.    

Prominent players operating in the cell culture reagents market include Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), and Sartorius AG (Germany), among others.

Don’t miss out on business opportunities in Cell Culture Reagents Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/